Full name
WINPHARM JASTRZĘBSKI I WSPÓLNICY SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
68.20.Z - Rental and operating of own or leased real estate
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
63.99.Z - Other information service activities not elsewhere classified
70.2 - Management consultancy activities
73.11.Z - Advertising agencies activities
82.20.Z - Activities of call centres
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4 | 1,5 | 2,2 | 45,8 |
EBITDA | 4,7 | 2,4 | 1,8 | -25,6 |
Short time liabilities | 2,4 | 4,6 | 2,1 | -54,1 |
Equity capital | 4,2 | 1,8 | 3,9 | 112 |
Operating profit (EBIT) | 4,1 | 1,8 | 1,1 | -36,3 |
Assets | 12,2 | 11,4 | 8,9 | -22,1 |
Net profit (loss) | 3,7 | 1,4 | 2,1 | 50,6 |
Cash | 0,2 | 0,3 | 1,2 | 263,5 |
Net income from sale | 4,4 | 4,7 | 5,5 | 16,9 |
Liabilities and provisions for liabilities | 8,1 | 9,6 | 5 | -47,9 |
Working assets | 1,8 | 1,4 | 2,8 | 102,7 |
Depreciation | 0,6 | 0,6 | 0,6 | 7,9 |
% | % | % | p.p. | |
Profitability of capital | 88,7 | 74,4 | 52,8 | -21,6 |
Equity capital to total assets | 34,1 | 16,1 | 43,9 | 27,8 |
Gross profit margin | 91,7 | 31,9 | 39,9 | 8 |
EBITDA Margin | 107 | 50,3 | 32 | -18,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 201 | 358 | 141 | -217 |
Current financial liquidity indicator | 0.752999484539032 | 0.2987641990184784 | 1.3182196617126465 | 1 |
Net dept to EBITDA | 1.2227216958999634 | 2.073713541030884 | 1.1257587671279907 | -1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane